Biom Pharmaceuticals' Antiviral Compound Bi121 Shows Broad-spectrum Activity Against Three Variants of SARS-CoV-2
Sarasota, Fla (PRWEB) February 03, 2022 -- Biom Pharmaceuticals announced today that the preclinical studies of antiviral preparation Bi121 showed significant
Source: prweb.com